Protection with N-acetyl-L-cysteine (NSC-111180) against isophosphamide (NSC-109724) toxicity and enhancement of therapeutic effect in early murine L1210 leukemia.
D000111:Acetylcysteine / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use / Q000633:toxicity*; D003498:Cyclic P-Oxides / Q000627:therapeutic use / Q000633:toxicity; D004357:Drug Synergism; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D007939:Leukemia L1210 / Q000188:drug therapy*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D009368:Neoplasm Transplantation; D009943:Organophosphorus Compounds / Q000627:therapeutic use / Q000633:toxicity*; D010078:Oxazines / Q000627:therapeutic use / Q000633:toxicity*; D013997:Time Factors; D014184:Transplantation, Homologous; D001745:Urinary Bladder Diseases / Q000139:chemically induced
D000970:Antineoplastic Agents; D003498:Cyclic P-Oxides; D009943:Organophosphorus Compounds; D010078:Oxazines; D000111:Acetylcysteine